Portage Biotech, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Public
- Established
- 1973-01-01
- Employees
- 7
- Market Cap
- $6.7M
TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors
Phase 1
Recruiting
- Conditions
- Renal Cell CancerCastrate Resistant Prostate CancerNon Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Cancer (CRC)Endometrial CancerOvarian Cancer
- Interventions
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Portage Biotech
- Target Recruit Count
- 90
- Registration Number
- NCT04969315
- Locations
- 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Norton Cancer Institute, Louisville, Kentucky, United States
🇺🇸The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath